Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Insulet Corp PODD

Healthcare Medical Devices
Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also... see more

Recent & Breaking News (NDAQ:PODD)

Insulet Updates Fourth Quarter Financial Guidance

Marketwired January 7, 2015

Insulet Corporation to Present at the 33rd Annual J.P. Morgan Healthcare Conference

Marketwired January 5, 2015

Insulet Corporation to Present at Upcoming Investor Conferences

Marketwired November 24, 2014

Insulet Corporation Appoints New Chief Financial Officer and Executive Vice President, Human Resources

Marketwired November 5, 2014

Insulet Reports Third Quarter 2014 Results

Marketwired November 5, 2014

Insulet Corporation to Present at Upcoming Investor Conferences

Marketwired November 3, 2014

Insulet Corporation to Report Third Quarter 2014 Financial Results on November 5, 2014

Marketwired October 21, 2014

Capricor Therapeutics Announces Plans to Pursue a Cenderitide Clinical Program and Enters Into Research Support Agreement With Insulet Corporation

GlobeNewswire October 9, 2014

Insulet Corporation Appoints Patrick J. Sullivan as President and Chief Executive Officer

Marketwired September 16, 2014

Insulet Corporation to Present at the Morgan Stanley Global Healthcare Conference

Marketwired September 2, 2014

Insulet Appoints Timothy J. Scannell to Board of Directors

Marketwired August 15, 2014

Insulet Reports Second Quarter 2014 Results

Marketwired August 7, 2014

Insulet and Dexcom Agree to Develop a CGM-Integrated Personal Diabetes Manager

Marketwired August 5, 2014

Insulet Corporation to Present at the Canaccord Genuity 34th Annual Growth Conference

Marketwired August 1, 2014

Insulet Corporation to Report Second Quarter 2014 Financial Results on August 7, 2014

Marketwired July 29, 2014

Insulet Corporation (NASDAQ: PODD) to Ring The NASDAQ Stock Market Closing Bell

GlobeNewswire July 29, 2014

DexCom's Forthcoming Mobile App Platform to Integrate Data from Insulet's OmniPod System

Business Wire June 13, 2014

Insulet Announces Pricing of Convertible Senior Notes

Marketwired June 4, 2014

Insulet Announces Public Offering of Convertible Senior Notes

Marketwired June 3, 2014

Insulet Corporation to Present at Upcoming Investor Conferences

Marketwired May 29, 2014